The role of NF-E2-related factor 2 in predicting chemoresistance and prognosis in advanced non-small-cell lung cancer. [electronic resource]
- Clinical lung cancer May 2011
- 166-71 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1938-0690
10.1016/j.cllc.2011.03.012 doi
Adult Aged Aged, 80 and over Carcinoma, Non-Small-Cell Lung--drug therapy Drug Resistance, Neoplasm Female Humans Immunohistochemistry Lung Neoplasms--drug therapy Male Middle Aged NF-E2-Related Factor 2--analysis Neoplasm Staging Prognosis Survival Rate